MAAT INDEX

CLAIM #22910 · EMR (EMR) · 2025Q3 earnings call · Aug 6, 2025 · due Feb 6, 2027

All 3 aspects of the business: greenfield, modernizations as well as continued MRO and competitive displacement is fueling the order growth, which will convert to sales over the next couple of years.

Ram Krishnan · COO

PENDING
graded after results covering Feb 6, 2027 are reported

How to check this claim

Look at: Net sales growth, driven by order backlog conversion, over the following two fiscal years

It came true if: Reported net sales growth > 0% year-over-year for FY2026 and FY2027

Where: Company income statement (10-K / quarterly earnings releases)

Verify independently

SEC filings for EMR · Claim quote is verbatim from the 2025Q3 earnings call.